These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 37089932)

  • 1. Postnatal corticosteroid exposure in very preterm infants: A French cohort study.
    Iacobelli S; Allamèle-Moutama K; Lorrain S; Gouyon B; Gouyon JB; Bonsante F;
    Front Pharmacol; 2023; 14():1170842. PubMed ID: 37089932
    [No Abstract]   [Full Text] [Related]  

  • 2. Early (< 8 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.
    Doyle LW; Cheong JL; Ehrenkranz RA; Halliday HL
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD001146. PubMed ID: 29063585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhaled versus systemic corticosteroids for the treatment of bronchopulmonary dysplasia in ventilated very low birth weight preterm infants.
    Shah SS; Ohlsson A; Halliday HL; Shah VS
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD002057. PubMed ID: 29035425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Glucocorticoide therapy in premature infants: French practices in 2006].
    Autret-Leca E; Bauer S; Alberti C; Jonville-Béra AP; Aujard Y; Bensouda-Grimaldi L; Baud O
    Arch Pediatr; 2009 Jul; 16(7):999-1004. PubMed ID: 19410441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dexamethasone, Prednisolone, and Methylprednisolone Use and 2-Year Neurodevelopmental Outcomes in Extremely Preterm Infants.
    Puia-Dumitrescu M; Wood TR; Comstock BA; Law JB; German K; Perez KM; Gogcu S; Mayock DE; Heagerty PJ; Juul SE;
    JAMA Netw Open; 2022 Mar; 5(3):e221947. PubMed ID: 35275165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The use of postnatal corticosteroid therapy in premature infants to prevent or treat bronchopulmonary dysplasia: current situation and recommendations].
    Jarreau PH; Fayon M; Baud O; Autret-Leca E; Danan M; de Verdelhan A; Castot A
    Arch Pediatr; 2010 Oct; 17(10):1480-7. PubMed ID: 20864322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late (≥ 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.
    Doyle LW; Cheong JL; Hay S; Manley BJ; Halliday HL
    Cochrane Database Syst Rev; 2021 Nov; 11(11):CD001145. PubMed ID: 34758507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early (< 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.
    Doyle LW; Cheong JL; Hay S; Manley BJ; Halliday HL
    Cochrane Database Syst Rev; 2021 Oct; 10(10):CD001146. PubMed ID: 34674229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Late (> 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants.
    Doyle LW; Cheong JL; Ehrenkranz RA; Halliday HL
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD001145. PubMed ID: 29063594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of early low-dose hydrocortisone on survival without bronchopulmonary dysplasia in extremely preterm infants (PREMILOC): a double-blind, placebo-controlled, multicentre, randomised trial.
    Baud O; Maury L; Lebail F; Ramful D; El Moussawi F; Nicaise C; Zupan-Simunek V; Coursol A; Beuchée A; Bolot P; Andrini P; Mohamed D; Alberti C;
    Lancet; 2016 Apr; 387(10030):1827-36. PubMed ID: 26916176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhaled versus systemic corticosteroids for preventing bronchopulmonary dysplasia in ventilated very low birth weight preterm neonates.
    Shah SS; Ohlsson A; Halliday HL; Shah VS
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD002058. PubMed ID: 29041034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early (< 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants.
    Halliday HL; Ehrenkranz RA; Doyle LW
    Cochrane Database Syst Rev; 2010 Jan; (1):CD001146. PubMed ID: 20091516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic corticosteroid regimens for prevention of bronchopulmonary dysplasia in preterm infants.
    Onland W; van de Loo M; Offringa M; van Kaam A
    Cochrane Database Syst Rev; 2023 Mar; 3(3):CD010941. PubMed ID: 36912887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhaled versus systemic corticosteroids for the treatment of chronic lung disease in ventilated very low birth weight preterm infants.
    Shah SS; Ohlsson A; Halliday H; Shah VS
    Cochrane Database Syst Rev; 2007 Oct; (4):CD002057. PubMed ID: 17943765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhaled versus systemic corticosteroids for the treatment of chronic lung disease in ventilated very low birth weight preterm infants.
    Shah SS; Ohlsson A; Halliday H; Shah VS
    Cochrane Database Syst Rev; 2003; (2):CD002057. PubMed ID: 12804423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caffeine dosing regimens in preterm infants with or at risk for apnea of prematurity.
    Bruschettini M; Brattström P; Russo C; Onland W; Davis PG; Soll R
    Cochrane Database Syst Rev; 2023 Apr; 4(4):CD013873. PubMed ID: 37040532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia.
    Bassler D
    Neonatology; 2015; 107(4):358-9. PubMed ID: 26044104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug exposure for PDA closure in France: a prospective, cohort-based, analysis.
    Iacobelli S; Lorrain S; Gouyon B; Gambacorta S; Laforgia N; Gouyon JB; Bonsante F
    Eur J Clin Pharmacol; 2020 Dec; 76(12):1765-1772. PubMed ID: 32740771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic corticosteroid regimens for prevention of bronchopulmonary dysplasia in preterm infants.
    Onland W; De Jaegere AP; Offringa M; van Kaam A
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD010941. PubMed ID: 28141913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.